<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30916132</article-id><article-id pub-id-type="pmc">6436790</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0272</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Innominate vs. Axillary Artery Cannulation in Aortic Surgery: a
Systematic Review and Meta-Analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5507-5841</contrib-id><name><surname>Harky</surname><given-names>Amer</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MRCS</role></contrib><contrib contrib-type="author"><name><surname>Chan</surname><given-names>Jeffrey SK</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MBBS</role></contrib><contrib contrib-type="author"><name><surname>Bithas</surname><given-names>Christiana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MBBS</role></contrib><contrib contrib-type="author"><name><surname>Hof</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Sharif</surname><given-names>Monira</given-names></name><xref ref-type="aff" rid="aff4">4</xref><role>BSc</role></contrib><contrib contrib-type="author"><name><surname>Froghi</surname><given-names>Saied</given-names></name><xref ref-type="aff" rid="aff5">5</xref><role>MRCS</role></contrib><contrib contrib-type="author"><name><surname>Bashir</surname><given-names>Mohamad</given-names></name><xref ref-type="aff" rid="aff6">6</xref><role>PhD</role></contrib></contrib-group><aff id="aff1">
<label>1</label> Department of Vascular Surgery, Countess of Chester, Chester,
United Kingdom of Great Britain and Northern Ireland.</aff><aff id="aff2">
<label>2</label> Faculty of Medicine, The Chinese University of Hong Kong, Hong
Kong, Region of the People's Republic of China.</aff><aff id="aff3">
<label>3</label> Department of Cardiovascular Surgery, Heinrich-Heine-University,
Medical Faculty, Dusseldrof, Germany.</aff><aff id="aff4">
<label>4</label> School of Medicine, University of Liverpool, Liverpool, United
Kingdom of Great Britain and Northern Ireland.</aff><aff id="aff5">
<label>5</label> Department of Surgery, Imperial College NHS Trust, Hammersmith
Hospital, Du Cane Rd London, United Kingdom of Great Britain and Northern
Ireland.</aff><aff id="aff6">
<label>6</label> Manchester Royal Infirmary, United Kingdom of Great Britain and
Northern Ireland.</aff><author-notes><corresp id="c1">Correspondence Address: <bold>Amer Harky</bold>,
https://orcid.org/0000-0001-5507-5841, Department of Vascular Surgery, Countess
of Chester Hospital, Countess of Chester Health Park, Liverpool Road, Chester,
United Kingdom of Great Britain and Northern Ireland, Zip code: CH2 1UL. E-mail:
<email>aaharky@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Mar-Apr</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2019</year></pub-date><volume>34</volume><issue>2</issue><fpage>213</fpage><lpage>221</lpage><history><date date-type="received"><day>05</day><month>9</month><year>2018</year></date><date date-type="accepted"><day>17</day><month>10</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To investigate whether axillary artery cannulation has supremacy over
innominate artery cannulation in thoracic aortic surgery.</p></sec><sec><title>Methods</title><p>A comprehensive search was undertaken among the four major databases (PubMed,
Excerpta Medica dataBASE [EMBASE], Scopus, and Ovid) to identify all
randomized and nonrandomized controlled trials comparing axillary to
innominate artery cannulation in thoracic aortic surgery. Databases were
evaluated and assessed up to March 2017.</p></sec><sec><title>Results</title><p>Only three studies fulfilled the criteria for this meta-analysis, including
534 patients. Cardiopulmonary bypass time was significantly shorter in the
innominate group (<italic>P</italic>=0.004). However, the innominate group
had significantly higher risk of prolonged intubation &#x0003e; 48 hours
(<italic>P</italic>=0.04) than the axillary group. Further analysis
revealed no significant difference between the innominate and axillary
groups for deep hypothermic circulatory arrest time
(<italic>P</italic>=0.06). The relative risks for temporary and permanent
neurological deficits as well as in-hospital mortality were not
significantly different for both groups (<italic>P</italic>=0.90,
<italic>P</italic>=0.49, and <italic>P</italic>=0.55, respectively).
Length of hospital stay was similar for both groups.</p></sec><sec><title>Conclusion</title><p>There is no superiority of axillary over innominate artery cannulation in
thoracic aortic surgery in terms of perioperative outcomes; however, as the
studies were limited, larger scale comparative studies are required to
provide a solid evidence base for choosing optimal arterial cannulation
site.</p></sec></abstract><kwd-group><kwd>Dissecting Aneurysm - Surgery</kwd><kwd>Thoracic Surgical Procedures</kwd><kwd>Axillary Artery</kwd><kwd>Peripheral Catherization - Methods</kwd><kwd>Treatment Outcomes</kwd></kwd-group></article-meta></front><body><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="42%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="42%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th><th align="center" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AATS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= American Association for
Thoracic Surgery</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NYHA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= New York Heart
Association</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ACP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Antegrade cerebral
perfusion</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PND</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Permanent neurological
deficits</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">Art</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Artery</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">POD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Presentation on
demand</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">BMI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Body mass index</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PRISMA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Preferred Reporting
Items for Systematic Reviews and Meta-Analyses</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">DHCA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Deep hypothermic
circulatory arrest</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RAA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Right axillary
artery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Confidence interval</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RCP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Retrograde cerebral
perfusion</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CKD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Chronic kidney
disease</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Standard deviation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">COPD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Chronic obstructive
pulmonary disease</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TND</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Temporary neurological
deficits</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">USA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= United States of
America</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EMBASE</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Excerpta Medica
dataBASE</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Innominate artery</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Thoracic aortic surgery entails complex and major procedures performed in specialized
centres by dedicated aortic surgeons. Such procedures are associated with
significant morbidity and mortality rates. Therefore, optimizing perioperative
outcomes in these circumstances is crucial for a satisfactory perioperative
recovery<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. A key factor
in determining such outcomes is the site of the arterial cannulation, which, upon
surgical planning, should be tailored as per individual patient<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Di Eusanio et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, among others, have shown that
selecting an ideal arterial cannulation site can have a favourable impact on
reducing neurological complications and lower mortality rates in patient with acute
type A aortic dissections. Regardless of cerebral perfusion and temperature
management, neurological injuries are the highest risk complications during aortic
arch surgery<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Currently, to
minimize such complications during aortic arch surgery, deep hypothermic circulatory
arrest (DHCA) with antegrade cerebral perfusion (ACP) is most widely used<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Aside from ACP, retrograde
cerebral perfusion (RCP) is also feasible and established in conjunction with
DHCA.</p><p>Over the past two decades, the ideal site of arterial in-flow has changed<sup>[<xref rid="r4" ref-type="bibr">4</xref>-<xref rid="r6" ref-type="bibr">6</xref>]</sup>. Initially, surgeons preferred to use femoral artery as the
main arterial cannulation with RCP. However, more recently, central cannulation has
become an alternative and safe perfusion site in acute aortic dissections or
patients with severe aortic atherosclerosis<sup>[<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p><p>Our systematic review focuses on two main central cannulation sites: the right
axillary artery (RAA) and the innominate artery (IA). Evidence from studies by Di
Eusanio et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup> suggests that
cannulation of RAA in patients undergoing surgery for atherosclerotic aneurysm and
organ malperfusion in acute type A aortic dissection can reduce the risk of cerebral
embolism during the antegrade blood flow through the thoracoabdominal aorta. It is
reported by Chu et al.<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup> that
cannulating RAA for systematic perfusion during circulatory arrest results in half
the incident rate of neurological events when compared to IA cannulation as an
access site for providing cerebral protection during aortic surgery, although the
difference was statistically insignificant.</p><p>Recently, the cannulation of IA has emerged as a popular choice over RAA
cannulation<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. It was
first introduced by Banbury and Cosgrove for cannulation in proximal aortic
surgery<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>. In recent
studies by Chu et al.<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup> and Di
Eusanio et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, IA cannulation
demonstrated a valid and safe alternative to RAA cannulation, and it is also a
simpler technique for establishing ACP as it requires no side graft in most cases.
Furthermore, Garg et al.<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>
demonstrated that for aortic arch reconstruction, cannulation of IA for ACP and DHCA
was both feasible and safe. Through adopting a technique to avoid separate axillary
cut down incisions, IA cannulation reduces the overall time required for surgery,
surgical mortality, and neurological injuries<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r9" ref-type="bibr">9</xref>]</sup>. IA cannulation is technically simpler in
comparison to RAA due to its larger size, providing an ideal blood flow rate during
cardiopulmonary bypass (CPB)<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>.
Furthermore, RAA involves increased risk of developing limb ischaemia, arm
hyper-perfusion, and seroma<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>.
Although evidence from Svensson et al.<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup> represents the global preference for IA cannulation over RAA
through retrospective studies, there has not been any high quality data to prove
that this technique is superior to RAA cannulation in providing appropriate cerebral
protection.</p><p>This paper aims to establish an understanding of the ideal site of cannulation to
enable the best perioperative outcome possible. Thus, we investigated whether
axillary artery has supremacy over IA cannulation during thoracic aortic
surgery.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Literature Search Strategy and Inclusion Criteria</title><p>Electronic database searches and screening were performed by two reviewers
independently using PubMed, Ovid, Scopus, and Excerpta Medica database (EMBASE)
to identify all randomized and nonrandomized controlled trials up to March 2017
that compared axillary to IA cannulation in thoracic aortic surgery. Limits were
placed to only include studies written in the English language that compared
clinical outcomes such as perioperative outcomes and mortality rates.
Non-comparative studies and studies that did not report clinical outcomes were
excluded. The search terms included axillary, innominate, brachiocephalic,
cannulation, aortic surgery, aorta, neurology, and outcomes. All search terms
were combined with Boolean operators and searched as both key words and MeSH
terms to ensure maximal sensitivity. After excluding articles based on title or
abstract, the following full text articles that were selected had their
reference lists searched for any potential further articles to be included in
this review.</p></sec><sec><title>Data Extraction and Critical Appraisal</title><p>The main outcome measures extracted included the following: in-hospital
mortality, temporary and permanent neurological deficits, and length of stay.
Other data were also extracted for assessment of perioperative characteristics
of patients. The quality of the studies included was assessed by the
Newcastle-Ottawa Scale, where each asterisk (*) represents one point, papers
with seven or more points provide a quality study (<xref rid="t1" ref-type="table">Table 1</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Newcastle-Ottawa Quality Assessment Scale.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Author</th><th align="center" colspan="4" rowspan="1">Selection</th><th align="center" rowspan="1" colspan="1">Comparability</th><th align="center" colspan="3" rowspan="1">Outcomes</th></tr><tr><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Representation of patients with RAA
cannulation</th><th align="center" rowspan="1" colspan="1">Selection of patients with IA cannulation</th><th align="center" rowspan="1" colspan="1">Ascertainment of exposure</th><th align="center" rowspan="1" colspan="1">Demonstration that the outcome of interest was
not present at the start of study</th><th align="center" rowspan="1" colspan="1">Indication of surgery = *</th><th align="center" rowspan="1" colspan="1">Assessment of outcomes</th><th align="center" rowspan="1" colspan="1">Follow-up long enough for outcomes to occur</th><th align="center" rowspan="1" colspan="1">Adequacy of follow-up of cohorts</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Svensson et al.<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup></td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td></tr><tr><td align="center" rowspan="1" colspan="1">Chu et al.<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup></td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td></tr><tr><td align="center" rowspan="1" colspan="1">Di Eusanio et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup></td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td><td align="center" rowspan="1" colspan="1">*</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>IA=innominate artery; RAA=right axillary artery</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Statistical Analysis</title><p>Standard descriptive statistics (reported as means, with 95% of confidence
interval [CI], were available) were used to summarize demographic and baseline
data of the patients from all eligible studies. Meta-analysis of reported
outcomes was performed on the reported in-hospital mortality, CPB time, DHCA
time, and, separately, temporary and permanent neurological deficits.</p><p>Heterogeneity was predominantly reported as the Chi<sup>2</sup> statistic, with
Tau<sup>2</sup> and I<sup>2</sup> statistics also calculated. Random effect
was estimated by the DerSimonian-Laird method. All statistical analyses were
conducted with Review Manager Version 5.1.2 (Cochrane Collaboration, Software
Update, Oxford, United Kingdom) and Stata Version 15.1 (StatCorp LLC, Texas,
United States of America [USA]).</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Study Characteristics</title><p>The aforementioned strategy revealed 2589 articles, of which 74 were selected for
full text review. During full text review, 62 papers were excluded as they were
non-comparative studies and they have included only single site cannulation
outcomes report. Furthermore, nine more papers were excluded as they were
comparisons between central and peripheral cannulation, without giving the
specific results of axillary <italic>vs</italic>. IA cannulation. Finally, three
comparative observational studies were included in the study<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r9" ref-type="bibr">9</xref>]</sup>. The search
strategy performed is summarized by a Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) chart in <xref ref-type="fig" rid="f1">Figure
1</xref>. A total of 534 patients were included in the analysis, of which
400 were cannulated via axillary artery and 134 were via IA. Characteristics of
the included studies are summarized in <xref rid="t2" ref-type="table">Table
2</xref>.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>PRISMA chart of literature search.</p><p>EMBASE=Excerpta Medica dataBASE; PRISMA=Preferred Reporting Items for
Systematic Reviews and Meta-Analyses</p></caption><graphic xlink:href="rbccv-34-02-0213-g01"/></fig>
</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Study characteristics of the articles included in the systematic reviews
and meta-analysis.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Author</th><th align="center" rowspan="1" colspan="1">Year</th><th align="center" rowspan="1" colspan="1">Country</th><th align="center" rowspan="1" colspan="1">Type</th><th align="center" rowspan="1" colspan="1">No. of patients</th><th align="center" rowspan="1" colspan="1">RAA (n)</th><th align="center" rowspan="1" colspan="1">IA (n)</th><th align="center" rowspan="1" colspan="1">Primary end points</th><th align="center" rowspan="1" colspan="1">Comments/Conclusion</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Svensson et al.<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup></td><td align="center" rowspan="1" colspan="1">2004</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">Prospective study</td><td align="center" rowspan="1" colspan="1">323</td><td align="center" rowspan="1" colspan="1">299</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">Stroke and mortality</td><td align="center" rowspan="1" colspan="1">Axillary inflow plus graft reduces stroke and is
the method of choice for complex cardiac and cardio-aortic
operations that necessitate circulatory arrest. Retrograde or
antegrade perfusion is used selectively.</td></tr><tr><td align="center" rowspan="1" colspan="1">Chu et al.<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup></td><td align="center" rowspan="1" colspan="1">2016</td><td align="center" rowspan="1" colspan="1">Canada</td><td align="center" rowspan="1" colspan="1">Prospective study</td><td align="center" rowspan="1" colspan="1">140</td><td align="center" rowspan="1" colspan="1">74</td><td align="center" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1">Clinical and neurological outcomes</td><td align="center" rowspan="1" colspan="1">Axillary and IA cannulation for ACP during
proximal aortic arch reconstructive surgery results in similarly
excellent neurological outcomes. IA cannulation might reduce
surgical time. Possible relevant differences in neurological and
respiratory complications require assessment in randomized
controlled trials.</td></tr><tr><td align="center" rowspan="1" colspan="1">Di Eusanio et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup></td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">Italy</td><td align="center" rowspan="1" colspan="1">Prospective study</td><td align="center" rowspan="1" colspan="1">71</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">Perioperative comorbidities and in-hospital
outcomes</td><td align="left" rowspan="1" colspan="1">RAA and IA were associated with similarly valid
results. The choice between the two, based on the specific
patient's characteristics, can improve outcomes after aortic
surgery.</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>ACP=antegrade cerebral perfusion; IA=innominate artery; RAA=right
axillary artery; USA=United States of America</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Perioperative Results</title><p>The key perioperative characteristics of patients included in this analysis are
summarized in <xref rid="t3" ref-type="table">Table 3</xref>. Patients who had
IA cannulation had higher body mass index (BMI) (28.4 &#x000b1; 4.5
kg/m<sup>2</sup> for IA cannulation <italic>vs</italic>. 27.25 &#x000b1; 3.45
kg/m<sup>2</sup> for RAA cannulation; <italic>P</italic>=0.0022) then those
who had RAA cannulation, however IA patients had less rates of chronic
obstructive pulmonary disease and history of smoking (21% for IA cannulation
<italic>vs</italic>. 44% for RAA cannulation; <italic>P</italic>=0.03) than
RAA patients. Moreover, RAA was cannulated in all cases of emergency thoracic
aortic surgeries and was significantly more likely to be cannulated in
non-emergency surgeries (84.40% for RAA cannulation <italic>vs</italic>. 15.60%
for IA cannulation; <italic>P</italic>=0.002). There was no significant
difference in total length of in-hospital stay among both cohorts of patients
(<italic>P</italic>=0.121).</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Perioperative characteristics and postoperative outcomes of patients
included in the analysis.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Right axillary artery cannulation</th><th align="center" rowspan="1" colspan="1">Innominate artery cannulation</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">No. of patients</td><td align="center" rowspan="1" colspan="1">N=400</td><td align="center" rowspan="1" colspan="1">N=134</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean age (years) &#x000b1;SD</td><td align="center" rowspan="1" colspan="1">63 &#x000b1;12</td><td align="center" rowspan="1" colspan="1">62&#x000b1;11</td><td align="center" rowspan="1" colspan="1">0.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Male (%)</td><td align="center" rowspan="1" colspan="1">278 (69.5)</td><td align="center" rowspan="1" colspan="1">61 (45.5)</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA III/IV (%)</td><td align="center" rowspan="1" colspan="1">17.75</td><td align="center" rowspan="1" colspan="1">5.22</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Reoperation (%)</td><td align="center" rowspan="1" colspan="1">13 (3)</td><td align="center" rowspan="1" colspan="1">23 (17)</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension (%)</td><td align="center" rowspan="1" colspan="1">268 (67)</td><td align="center" rowspan="1" colspan="1">60 (44)</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus (%)</td><td align="center" rowspan="1" colspan="1">85 (21)</td><td align="center" rowspan="1" colspan="1">7 (5)</td><td align="center" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">COPD (%)</td><td align="center" rowspan="1" colspan="1">227 (57)</td><td align="center" rowspan="1" colspan="1">32 (24)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (mean &#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">27.25&#x000b1;3.45</td><td align="center" rowspan="1" colspan="1">28.4&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">0.0022</td></tr><tr><td align="left" rowspan="1" colspan="1">CKD/renal failure (%)</td><td align="center" rowspan="1" colspan="1">20 (5)</td><td align="center" rowspan="1" colspan="1">1 (1)</td><td align="center" rowspan="1" colspan="1">0.321</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking history - COPD (%)</td><td align="center" rowspan="1" colspan="1">176 (44)</td><td align="center" rowspan="1" colspan="1">28 (21)</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">Surgical acuity</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Emergency (%)</td><td align="center" rowspan="1" colspan="1">162 (40)</td><td align="center" rowspan="1" colspan="1">113 (85)</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Non-emergency (%)</td><td align="center" rowspan="1" colspan="1">238 (60)</td><td align="center" rowspan="1" colspan="1">21 (15)</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Operative data</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB (mins) (mean &#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">167.45&#x000b1;54.67</td><td align="center" rowspan="1" colspan="1">173.12&#x000b1;51.85</td><td align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">DHCA (mins) (mean &#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">29.14 &#x000b1;23.55</td><td align="center" rowspan="1" colspan="1">38.48&#x000b1;31.32</td><td align="center" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative data</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">TND<sup><xref ref-type="table-fn" rid="TFN3">a</xref></sup> (%)</td><td align="center" rowspan="1" colspan="1">12 (3)</td><td align="center" rowspan="1" colspan="1">13 (10)</td><td align="center" rowspan="1" colspan="1">0.90</td></tr><tr><td align="left" rowspan="1" colspan="1">PND<sup><xref ref-type="table-fn" rid="TFN4">b</xref></sup> (%)</td><td align="center" rowspan="1" colspan="1">14 (4)</td><td align="center" rowspan="1" colspan="1">6 (5)</td><td align="center" rowspan="1" colspan="1">0.49</td></tr><tr><td align="left" rowspan="1" colspan="1">Reoperation for bleeding (%)</td><td align="center" rowspan="1" colspan="1">25 (6)</td><td align="center" rowspan="1" colspan="1">11 (8)</td><td align="center" rowspan="1" colspan="1">0.93</td></tr><tr><td align="left" rowspan="1" colspan="1">In-hospital mortality (%)</td><td align="center" rowspan="1" colspan="1">24 (6)</td><td align="center" rowspan="1" colspan="1">7 (5)</td><td align="center" rowspan="1" colspan="1">0.55</td></tr><tr><td align="left" rowspan="1" colspan="1">Renal failure (%)</td><td align="center" rowspan="1" colspan="1">23 (6)</td><td align="center" rowspan="1" colspan="1">14 (10)</td><td align="center" rowspan="1" colspan="1">0.89</td></tr><tr><td align="left" rowspan="1" colspan="1">Cannulation related complications (%)</td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Prolonged intubation &#x0003e;48 hrs (%)</td><td align="center" rowspan="1" colspan="1">22 (6)</td><td align="center" rowspan="1" colspan="1">10 (8)</td><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">Sepsis (%)</td><td align="center" rowspan="1" colspan="1">32 (8)</td><td align="center" rowspan="1" colspan="1">1 (1)</td><td align="center" rowspan="1" colspan="1">0.95</td></tr><tr><td align="left" rowspan="1" colspan="1">Hospital stay - days (mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">7&#x000b1;6</td><td align="center" rowspan="1" colspan="1">6&#x000b1;4</td><td align="center" rowspan="1" colspan="1">0.121</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><label>a</label><p>Includes transient ischaemic attacks, delirium, and confusion.</p></fn><fn id="TFN4"><label>b</label><p>Includes stroke and hypoxic brain injury.</p></fn><fn id="TFN5"><p>BMI=body-mass index; CKD=chronic kidney disease; COPD=chronic
obstructive pulmonary disease; CPB=cardiopulmonary bypass; DHCA=deep
hypothermic circulatory arrest; NYHA=New York Heart Association;
PND=permanent neurological deficits; SD=standard deviation;
TND=temporary neurological deficits</p></fn></table-wrap-foot></table-wrap><p>Selected in-hospital postoperative outcomes were measured and they are summarized
in <xref rid="t3" ref-type="table">Table 3</xref>. The meta-analysis was carried
out for in-hospital mortality, DHCA time, CPB time, rates of temporary and
permanent neurological deficits, rates of prolonged intubation &#x0003e; 48 hours,
rates of reoperation for bleeding, and rates of postoperative renal failure.
There was no significant difference between the two cannulations sites for
in-hospital mortality rate (<italic>P</italic>=0.55; <xref ref-type="fig" rid="f2">Figure 2</xref>), DHCA time (<italic>P</italic>=0.06; <xref ref-type="fig" rid="f3">Figure 3</xref>), temporary
(<italic>P</italic>=0.90; <xref ref-type="fig" rid="f4">Figure 4</xref>) and
permanent (<italic>P</italic>=0.49; <xref ref-type="fig" rid="f5">Figure
5</xref>) neurological deficits, rates of reoperation for bleeding
(<italic>P</italic>=0.93; <xref ref-type="fig" rid="f6">Figure 6</xref>),
and rates of postoperative renal failure (<italic>P</italic>=0.89; <xref ref-type="fig" rid="f7">Figure 7</xref>). The data of the rates of
reoperation for bleeding was significantly heterogenous (Chi<sup>2</sup>=7.10,
df=2, <italic>P</italic>=0.03). On the other hand, CPB time was significantly
shorter in cases where IA was cannulated (<italic>P</italic>=0.004; <xref ref-type="fig" rid="f8">Figure 8</xref>) than in axillary cases.
Nevertheless, IA cannulation was also associated with significantly higher risks
of prolonged intubation &#x0003e; 48 hours (<italic>P</italic>=0.04; <xref ref-type="fig" rid="f9">Figure 9</xref>) than axillary cannulation. Other
measured in-hospital postoperative outcomes were not significantly different
between the two groups, including the rate of sepsis and cannulation-related
complications (<italic>P</italic>&#x0003e;0.05).</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>In-hospital mortality.</p><p>Art=artery; CI=confidence interval</p></caption><graphic xlink:href="rbccv-34-02-0213-g02"/></fig>
</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Deep hypothermic circulatory arrest time.</p><p>Art.=artery; CI=confidence interval; SD=standard deviation</p></caption><graphic xlink:href="rbccv-34-02-0213-g03"/></fig>
</p><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Temporary neurological deficit rate.</p><p>Art.=artery; CI=confidence interval</p></caption><graphic xlink:href="rbccv-34-02-0213-g04"/></fig>
</p><p>
<fig id="f5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Permanent neurological deficit rate.</p><p>Art.=artery; CI=confidence interval</p></caption><graphic xlink:href="rbccv-34-02-0213-g05"/></fig>
</p><p>
<fig id="f6" orientation="portrait" position="float"><label>Fig. 6</label><caption><p>Rate of reoperation for bleeding.</p><p>Art.=artery; CI=confidence interval</p></caption><graphic xlink:href="rbccv-34-02-0213-g06"/></fig>
</p><p>
<fig id="f7" orientation="portrait" position="float"><label>Fig. 7</label><caption><p>Rate of postoperative renal failure.</p><p>Art.=artery; CI=confidence interval</p></caption><graphic xlink:href="rbccv-34-02-0213-g07"/></fig>
</p><p>
<fig id="f8" orientation="portrait" position="float"><label>Fig. 8</label><caption><p>Cardiopulmonary bypass time.</p><p>Art.=artery; CI=confidence interval; SD=standard deviation</p></caption><graphic xlink:href="rbccv-34-02-0213-g08"/></fig>
</p><p>
<fig id="f9" orientation="portrait" position="float"><label>Fig. 9</label><caption><p>Rate of prolonged intubation &#x0003e;48 hours.</p><p>Art.=artery; CI=confidence interval</p></caption><graphic xlink:href="rbccv-34-02-0213-g09"/></fig>
</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In the past five decades, the optimal site for arterial cannulation has evolved
according to attempts to improve perioperative outcomes such as survival rates and
detrimental neurological impacts in patients who underwent complex aortic
surgeries<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r13" ref-type="bibr">13</xref>]</sup>. Examples
of previously used cannulation sites include the femoral and subclavian arteries,
and, more recently, the distal ascending aorta<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>. However, the distal ascending aortic inflow route of
cannulation is associated with increased risks of lower limb ischaemia, lack of ACP
use, dissection, and stroke<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r13" ref-type="bibr">13</xref>]</sup>. As such, an overwhelming volume
of studies have provided evidence of the beneficial outcomes of using cannulation
sites amongst branches of the ascending aorta and the aortic arch, such as RAA and
IA<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r9" ref-type="bibr">9</xref>]</sup>.
Cannulation of the axillary artery using side graft with ACP has been shown to
provide better perioperative outcomes than classical cannulation sites<sup>[<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r13" ref-type="bibr">13</xref>]</sup>. More specifically, RAA cannulation reduces the probability of
malperfusion, atheroma or calcified plaque disruption, and thromboembolic
stroke<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. More recently,
IA is becoming the preferred site of cannulation during hemi-arch reconstruction. It
provides similar advantages to those of RAA cannulation, such as lower rate of
surgical complication, including neurological injury or surgical
mortality<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. On the other
hand, IA is not risk free and it is also associated with risks, such as arterial
dissection<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>With these trends in surgical approaches in mind, this meta-analysis aimed to compare
the different intraoperative and postoperative outcomes of IA and RAA cannulations
in patients undergoing thoracic aortic surgery. Pooling of the data from available
evidence did not show any statistical difference (<italic>P</italic>=0.55) in the
in-hospital mortality between RAA (6%) and IA (5.22%) cannulation. Both permanent
and temporary neurological deficits have not been found to be significantly
different between RAA and IA cannulation either; RAA and IA cannulation led to 3.5%
and 4.48% cases of permanent neurological deficits (<italic>P</italic>=0.49), and 3%
and 9.70% cases of temporary neurological deficits (<italic>P</italic>=0.90),
respectively. This is consistent with previously reported findings, including the
ones by Etz et al.<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>, which
included 608 patients cannulated at the ascending aorta or RAA, finding no
difference between RAA and other cannulations sites in terms of survival and
neurological outcomes<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>Furthermore, there was no significant difference in post-operative sepsis incidence
(<italic>P</italic>=0.95) for RAA (8%) compared to IA cannulation (0.75%), as
well as post-operative renal failure (<italic>P</italic>=0.89), 5% and 0.75% for RAA
and IA, respectively. Moreover, the analysis did not demonstrate any significant
difference in the mean duration of DHCA in both groups of patients (29.14 &#x000b1;
23.55 minutes for RAA cannulation and 38.48 &#x000b1; 31.32 minutes for IA
cannulation; <italic>P</italic>=0.06). These outcomes were consistent with the
existing literature by Chu et al. (24 &#x000b1; 5 minutes for RAA cannulation and 22
&#x000b1; 7 minutes for IA cannulation respectively; <italic>P</italic>=0.001), with
Di Eusanio et al. being also unable to demonstrate any significant difference (78
&#x000b1; 34 minutes for RAA cannulation and 70 &#x000b1; 35 minutes for IA
cannulation<italic>; P</italic>=0.625)<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>In addition, this meta-analysis showed no significant difference in the rate of
reoperation for bleeding (6.25% for RAA cannulation and 8.21% for IA cannulation;
<italic>P</italic>=0.93). This confirms the findings from the study by Di
Eusanio et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, who also found
no significant difference in reoperation rate between the two approaches (48.1% for
RAA cannulation and 52.3% for IA cannulation; <italic>P</italic>=0.463).</p><p>Nevertheless, IA cannulation was associated with shorter CPB duration
(<italic>P</italic>=0.004), with a mean time of 173.12&#x000b1; 51.85 minutes and
167.45 &#x000b1; 54.67 minutes for RAA and IA cannulation, respectively
(<italic>P</italic>=0.004). This builds on the observed and statistically
significant decrease in the CPB time of IA cannulation (202 &#x000b1; 60 minutes and
196 &#x000b1; 55 minutes for RAA and IA cannulation, respectively,
<italic>P</italic>=0.727) by Di Eusanio et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, and it is reasonable in view of RAA cannulation as a more
technically demanding and time-consuming procedure<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r9" ref-type="bibr">9</xref>]</sup>. Though not
specifically investigated in this meta-analysis for the setting of thoracic aortic
surgery, CPB time has been shown to correlate independently with mortality and
morbidity<sup>[<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>]</sup>. Moreover, shorter CPB time and
technical demands in IA cannulation than in RAA cannulation may, in turn, reduce the
mean procedural time and thus increase the efficiency and volume of care, especially
in high-volume centres<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r12" ref-type="bibr">12</xref>]</sup>. Therefore, our results provide a
possible justification for the preference for IA over RAA cannulation.</p><p>On the other hand, IA cannulation has been found to be associated with higher rates
of prolonged intubation &#x0003e; 48 hours (6% in RAA cannulation and 8% in IA
cannulation; <italic>P</italic>=0.04). This happens despite statistically
non-significant findings by Chu et al.<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup> (18% in RAA cannulation and 8% in IA cannulation;
<italic>P</italic>=0.078) and Di Eusanio et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>(30% in RAA cannulation and 11% in IA cannulation;
<italic>P</italic>=0.055). This finding should be interpreted with caution since
the data is heavily skewed by the outcomes reported in the study by Svensson et
al.<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup> (1 out of 299
patients with RAA cannulation and 0 out of 24 patients with IA cannulation).
Nonetheless, prolonged intubation has been shown to be associated with significantly
higher mortality and respiratory complications<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>. As such, this may be a possible counterargument against
the preferential choice of IA cannulation over RAA cannulation.</p><sec><title>Limitations</title><p>Interpretation of this meta-analysis must consider several limiting factors.
Firstly, all the included studies are prospective studies without any
randomization. This presents a significant source of potential bias which may
confound the data. Secondly, not all variables were reported across all studies.
Particularly, the length of stay in hospital and intensive care units were only
reported by Chu et al.<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>, and,
as such, it cannot be meta-analysed. This constitutes a significant limitation
of this study, since the above two variables are important outcome measures, and
the lack of them significantly impacts the comprehensiveness of the evaluation
of RAA and IA cannulations. Thirdly, publication bias may have confounded the
results, as observational studies with undesirable outcomes may not have
published their results in full. Fourthly, this study did not consider the
volume and expertise of the centres and surgeons involved, which have been shown
to have substantial impact on mortality and morbidity rates in previous
works<sup>[<xref rid="r18" ref-type="bibr">18</xref>-<xref rid="r22" ref-type="bibr">22</xref>]</sup>. Finally, this meta-analysis
only included three studies. Hence, the analysis results may not be broadly
representative of patients receiving thoracic aortic surgery, and the
statistical representativeness of the study is inevitably limited due to the few
studies included.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>The results from this meta-analysis demonstrate no significant difference in
perioperative outcomes of using either axillary or IA cannulation during thoracic
aortic surgery. Given the limitations of the analysis which includes only three
comparative studies, the results must be interpreted carefully, and this highlight
the need of a randomized trial comparing both techniques to understand the potential
differences between each cannulation option on a larger, multi-centre level. Until
then, the choice of site for cannulation in thoracic aortic surgery remains upon the
operating surgeon's preference.</p><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">AH</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">JSKC</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CB</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AH</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MS</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SF</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MB</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Department of Vascular Surgery, Countess of
Chester, Chester, United Kingdom of Great Britain and Northern Ireland.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="other"><p>Meeting Presentation This abstract has been presented as a poster (presentation
on demand [POD]) at the American Association for Thoracic Surgery (AATS) aortic
symposium, April 26-27, 2018, New York - USA.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>V</given-names></name><name><surname>Peterson</surname><given-names>MD</given-names></name><name><surname>Chu</surname><given-names>MW</given-names></name><name><surname>Ouzounian</surname><given-names>M</given-names></name><name><surname>MacArthur</surname><given-names>RG</given-names></name><name><surname>Bozinovski</surname><given-names>J</given-names></name><etal/></person-group><article-title>Axillary versus innominate artery cannulation for antegrade
cerebral perfusion in aortic surgery: design of the Aortic Surgery Cerebral
Protection Evaluation (ACE) CardioLink-3 randomised trial</article-title><source>BMJ Open</source><day>10</day><month>6</month><year>2017</year><volume>7</volume><issue>6</issue><elocation-id>e014491</elocation-id><pub-id pub-id-type="doi">10.1136/bmjopen-2016-014491</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>A</given-names></name><name><surname>El Ghanam</surname><given-names>M</given-names></name><name><surname>Mourad</surname><given-names>F</given-names></name><name><surname>Mostafa</surname><given-names>A</given-names></name></person-group><article-title>Innominate artery cannulation for Thoracic Aortic surgery. A safe
alternative</article-title><source>J Egypt Soc Cardio-Thoracic Surg</source><year>2017</year><issue>25</issue><fpage>14</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/J.JESCTS.2017.02.001</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Eusanio</surname><given-names>M</given-names></name><name><surname>Dimitri Petridis</surname><given-names>F</given-names></name><name><surname>Folesani</surname><given-names>G</given-names></name><name><surname>Berretta</surname><given-names>P</given-names></name><name><surname>Zardin</surname><given-names>D</given-names></name><etal/></person-group><article-title>Axillary and innominate artery cannulation during surgery of the
thoracic aorta: a comparative study</article-title><source>J Cardiovasc Surg (Torino)</source><month>12</month><year>2014</year><volume>55</volume><issue>6</issue><fpage>841</fpage><lpage>847</lpage></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svensson</surname><given-names>LG</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name><name><surname>Rajeswaran</surname><given-names>J</given-names></name><name><surname>Sabik 3rd</surname><given-names>JF</given-names></name><name><surname>Lytle</surname><given-names>BW</given-names></name><name><surname>Gonzalez-Stawinski</surname><given-names>G</given-names></name><etal/></person-group><article-title>Does the arterial cannulation site for circulatory arrest
influence stroke risk?</article-title><source>Ann Thorac Surg</source><month>10</month><year>2004</year><volume>78</volume><issue>4</issue><fpage>1274</fpage><lpage>1284</lpage><pub-id pub-id-type="pmid">15464485</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Eusanio</surname><given-names>M</given-names></name><name><surname>Ciano</surname><given-names>M</given-names></name><name><surname>Labriola</surname><given-names>G</given-names></name><name><surname>Lionetti</surname><given-names>G</given-names></name><name><surname>Di Eusanio</surname><given-names>G</given-names></name></person-group><article-title>Cannulation of the innominate artery during surgery of the
thoracic aorta: our experience in 55 patients</article-title><source>Eur J Cardiothorac Surg</source><month>8</month><year>2007</year><volume>32</volume><issue>2</issue><fpage>270</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">17553687</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apostolakis</surname><given-names>EE</given-names></name><name><surname>Baikoussis</surname><given-names>NG</given-names></name><name><surname>Katsanos</surname><given-names>K</given-names></name><name><surname>Karanikolas</surname><given-names>M</given-names></name></person-group><article-title>Postoperative peri-axillary seroma following axillary artery
cannulation for surgical treatment of acute type A aortic
dissection</article-title><source>J Cardiothorac Surg</source><day>25</day><month>5</month><year>2010</year><volume>5</volume><fpage>43</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1186/1749-8090-5-43</pub-id><pub-id pub-id-type="pmid">20500837</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etz</surname><given-names>CD</given-names></name><name><surname>von Aspern</surname><given-names>K</given-names></name><name><surname>da Rocha E Silva</surname><given-names>J</given-names></name><name><surname>Girrbach</surname><given-names>FF</given-names></name><name><surname>Leontyev</surname><given-names>S</given-names></name><name><surname>Luehr</surname><given-names>M</given-names></name><etal/></person-group><article-title>Impact of perfusion strategy on outcome after repair for acute
type a aortic dissection</article-title><source>Ann Thorac Surg</source><month>1</month><year>2014</year><volume>97</volume><issue>1</issue><fpage>78</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2013.07.034</pub-id><pub-id pub-id-type="pmid">24070704</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etz</surname><given-names>CD</given-names></name><name><surname>Plestis</surname><given-names>KA</given-names></name><name><surname>Kari</surname><given-names>FA</given-names></name><name><surname>Silovitz</surname><given-names>D</given-names></name><name><surname>Bodian</surname><given-names>CA</given-names></name><name><surname>Spielvogel</surname><given-names>D</given-names></name><etal/></person-group><article-title>Axillary cannulation significantly improves survival and
neurologic outcome after atherosclerotic aneurysm repair of the aortic root
and ascending aorta</article-title><source>Ann Thorac Surg</source><month>8</month><year>2008</year><volume>86</volume><issue>2</issue><fpage>441</fpage><lpage>446</lpage><comment>discussion 446-7</comment><pub-id pub-id-type="doi">10.1016/j.athoracsur.2008.02.083</pub-id><pub-id pub-id-type="pmid">18640312</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>MW</given-names></name><name><surname>Losenno</surname><given-names>KL</given-names></name><name><surname>Gelinas</surname><given-names>JJ</given-names></name><name><surname>Garg</surname><given-names>V</given-names></name><name><surname>Dickson</surname><given-names>J</given-names></name><name><surname>Harrington</surname><given-names>A</given-names></name><etal/></person-group><article-title>Innominate and Axillary Cannulation in Aortic Arch Surgery
Provide Similar Neuroprotection</article-title><source>Can J Cardiol</source><month>1</month><year>2016</year><volume>32</volume><issue>1</issue><fpage>117</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.cjca.2015.07.013</pub-id><pub-id pub-id-type="pmid">26549866</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harky</surname><given-names>A</given-names></name><name><surname>Wong</surname><given-names>CHM</given-names></name><name><surname>Chan</surname><given-names>JSK</given-names></name><name><surname>Zaki</surname><given-names>S</given-names></name><name><surname>Froghi</surname><given-names>S</given-names></name><name><surname>Bashir</surname><given-names>M</given-names></name></person-group><article-title>Innominate artery cannulation in aortic surgery: A systematic
review</article-title><source>J Card Surg</source><month>12</month><year>2018</year><volume>33</volume><issue>12</issue><fpage>818</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1111/jocs.13962</pub-id><pub-id pub-id-type="pmid">30548686</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banbury</surname><given-names>MK</given-names></name><name><surname>Cosgrove 3rd</surname><given-names>DM</given-names></name></person-group><article-title>Arterial cannulation of the innominate artery</article-title><source>Ann Thorac Surg</source><month>3</month><year>2000</year><volume>69</volume><issue>3</issue><fpage>957</fpage><lpage>957</lpage><pub-id pub-id-type="pmid">10750803</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>V</given-names></name><name><surname>Tsirigotis</surname><given-names>DN</given-names></name><name><surname>Dickson</surname><given-names>J</given-names></name><name><surname>Dalamagas</surname><given-names>C</given-names></name><name><surname>Latter</surname><given-names>DA</given-names></name><name><surname>Verma</surname><given-names>S</given-names></name><etal/></person-group><article-title>Direct innominate artery cannulation for selective antegrade
cerebral perfusion during deep hypothermic circulatory arrest in aortic
surgery</article-title><source>J Thorac Cardiovasc Surg</source><month>12</month><year>2014</year><volume>148</volume><issue>6</issue><fpage>2920</fpage><lpage>2924</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2014.07.021</pub-id><pub-id pub-id-type="pmid">25172323</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabik</surname><given-names>JF</given-names></name><name><surname>Lytle</surname><given-names>BW</given-names></name><name><surname>McCarthy</surname><given-names>PM</given-names></name><name><surname>Cosgrove</surname><given-names>DM</given-names></name></person-group><article-title>Axillary artery: an alternative site of arterial cannulation for
patients with extensive aortic and peripheral vascular
disease</article-title><source>J Thorac Cardiovasc Surg</source><month>5</month><year>1995</year><volume>109</volume><issue>5</issue><fpage>885</fpage><lpage>890</lpage><pub-id pub-id-type="pmid">7739248</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamou</surname><given-names>SC</given-names></name><name><surname>Gartner</surname><given-names>D</given-names></name><name><surname>Kouchoukos</surname><given-names>NT</given-names></name><name><surname>Lobdell</surname><given-names>KW</given-names></name><name><surname>Khabbaz</surname><given-names>K</given-names></name><name><surname>Murphy</surname><given-names>E</given-names></name><etal/></person-group><article-title>Axillary Versus Femoral Arterial Cannulation During Repair of
Type A Aortic Dissection?: An Old Problem Seeking New
Solutions</article-title><source>Aorta (Stamford)</source><day>01</day><month>8</month><year>2016</year><volume>4</volume><issue>4</issue><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.12945/j.aorta.2016.16.007</pub-id><pub-id pub-id-type="pmid">28097193</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madhavan</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>SP</given-names></name><name><surname>Tan</surname><given-names>WC</given-names></name><name><surname>Eng</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Luo</surname><given-names>HD</given-names></name><etal/></person-group><article-title>Cardiopulmonary bypass time: every minute counts</article-title><source>J Cardiovasc Surg (Torino)</source><month>4</month><year>2018</year><volume>59</volume><issue>2</issue><fpage>274</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.23736/S0021-9509.17.09864-0</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salis</surname><given-names>S</given-names></name><name><surname>Mazzanti</surname><given-names>VV</given-names></name><name><surname>Merli</surname><given-names>G</given-names></name><name><surname>Salvi</surname><given-names>L</given-names></name><name><surname>Tedesco</surname><given-names>CC</given-names></name><name><surname>Veglia</surname><given-names>F</given-names></name><etal/></person-group><article-title>Cardiopulmonary bypass duration is an independent predictor of
morbidity and mortality after cardiac surgery</article-title><source>J Cardiothorac Vasc Anesth</source><month>12</month><year>2008</year><volume>22</volume><issue>6</issue><fpage>814</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1053/j.jvca.2008.08.004</pub-id><pub-id pub-id-type="pmid">18948034</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bostock</surname><given-names>IC</given-names></name><name><surname>Zarkowsky</surname><given-names>DS</given-names></name><name><surname>Hicks</surname><given-names>CW</given-names></name><name><surname>Stone</surname><given-names>DH</given-names></name><name><surname>Malas</surname><given-names>MB</given-names></name><name><surname>Goodney</surname><given-names>PP</given-names></name></person-group><article-title>Outcomes and Risk Factors Associated with Prolonged Intubation
after EVAR</article-title><source>Ann Vasc Surg</source><month>7</month><year>2018</year><volume>50</volume><fpage>167</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/j.avsg.2017.11.063</pub-id><pub-id pub-id-type="pmid">29481928</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bottle</surname><given-names>A</given-names></name><name><surname>Mariscalco</surname><given-names>G</given-names></name><name><surname>Shaw</surname><given-names>MA</given-names></name><name><surname>Benedetto</surname><given-names>U</given-names></name><name><surname>Saratzis</surname><given-names>A</given-names></name><name><surname>Mariani</surname><given-names>S</given-names></name><etal/></person-group><article-title>Unwarranted Variation in the Quality of Care for Patients With
Diseases of the Thoracic Aorta</article-title><source>J Am Heart Assoc</source><day>14</day><month>3</month><year>2017</year><volume>6</volume><issue>3</issue><!--<pub-id pub-id-type="pii">e004913</pub-id>--><pub-id pub-id-type="doi">10.1161/JAHA.116.004913</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyata</surname><given-names>H</given-names></name><name><surname>Motomura</surname><given-names>N</given-names></name><name><surname>Ueda</surname><given-names>Y</given-names></name><name><surname>Tsukihara</surname><given-names>H</given-names></name><name><surname>Tabayashi</surname><given-names>K</given-names></name><name><surname>Takamoto</surname><given-names>S</given-names></name></person-group><article-title>Toward quality improvement of thoracic aortic surgery: estimating
volume-outcome effect from nationwide survey</article-title><source>Eur J Cardiothorac Surg</source><month>9</month><year>2009</year><volume>36</volume><issue>3</issue><fpage>517</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1016/j.ejcts.2009.03.020</pub-id><pub-id pub-id-type="pmid">19409802</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>GC</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Rankin</surname><given-names>JS</given-names></name><name><surname>Scarborough</surname><given-names>JE</given-names></name><name><surname>O'Brien</surname><given-names>S</given-names></name><name><surname>Bavaria</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Effects of institutional volumes on operative outcomes for aortic
root replacement in North America</article-title><source>J Thorac Cardiovasc Surg</source><month>1</month><year>2013</year><volume>145</volume><issue>1</issue><fpage>166</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2011.10.094</pub-id><pub-id pub-id-type="pmid">22306215</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalegre</surname><given-names>ST</given-names></name><name><surname>S&#x000e1;</surname><given-names>MP</given-names></name><name><surname>de Rueda</surname><given-names>FG</given-names></name><name><surname>Salerno</surname><given-names>PR</given-names></name><name><surname>Vasconcelos</surname><given-names>FP</given-names></name><name><surname>Lima</surname><given-names>RC</given-names></name></person-group><article-title>Central versus peripheral arterial cannulation and neurological
outcomes after thoracic aortic surgery: meta-analysis and meta-regression of
4459 patients</article-title><source>Perfusion</source><month>7</month><year>2015</year><volume>30</volume><issue>5</issue><fpage>383</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1177/0267659114547379</pub-id><pub-id pub-id-type="pmid">25138243</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harky</surname><given-names>A</given-names></name><name><surname>Bashir</surname><given-names>M</given-names></name><name><surname>Shaw</surname><given-names>M</given-names></name><name><surname>Howard</surname><given-names>C</given-names></name><name><surname>Sharif</surname><given-names>M</given-names></name><name><surname>Oo</surname><given-names>A</given-names></name></person-group><article-title>Aortic cannulation in complex aortic disease: playing or planning
on fear</article-title><source>J Vis Surg</source><year>2019</year><volume>5</volume><fpage>18</fpage><lpage>18</lpage></element-citation></ref></ref-list></back></article>